Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 8c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.70), $0.08 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• JPMorgan Reiterates Overweight Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in